Literature DB >> 16436653

Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.

Markus Wörnle1, Holger Schmid, Bernhard Banas, Monika Merkle, Anna Henger, Maximilian Roeder, Simone Blattner, Elisabeth Bock, Matthias Kretzler, Hermann-Josef Gröne, Detlef Schlöndorff.   

Abstract

Hepatitis C virus (HCV) infection is frequently complicated by glomerulonephritis with immune complexes containing viral RNA. We examined the potential influence of Toll-like receptors (TLRs), specifically TLR3 recognition of viral dsRNA exemplified by polyriboinosinic:polyribocytidylic acid [poly(I:C) RNA]. Normal human kidney stained positive for TLR3 on mesangial cells (MCs), vascular smooth muscle cells, and collecting duct epithelium. Cultured MCs have low TLR3 mRNA levels with predominant intracellular protein localization, which was increased by tumor necrosis factor-alpha, interleukin (IL)-1beta, interferon (IFN)-gamma, and the TLR3 ligand poly(I:C) RNA. Poly(I:C) RNA stimulation of MCs increased mRNA and protein synthesis of IL-6, IL-1beta, M-CSF, IL-8/CXCL8, RANTES/CCL5, MCP-1/CCL2, and ICAM-I; it also increased anti-proliferative and proapoptotic effects, the latter of which was decreased by inhibiting caspase-8. In microdissected glomeruli of normal and non-HCV membranoproliferative glomerulonephritis biopsies, TLR3 mRNA expression was low. In contrast TLR3 mRNA expression was significantly increased in hepatitis C-positive glomerulonephritis and was associated with enhanced mRNA for RANTES/CCL5 and MCP-1/CCL2. We hypothesize that immune complexes containing viral RNA activate mesangial TLR3 during HCV infection, thereby contributing to chemokine/cytokine release and effecting proliferation and apoptosis. Thus, TLR3 expression on renal cells, and especially MCs, may establish a link between viral infections and glomerular diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436653      PMCID: PMC1606499          DOI: 10.2353/ajpath.2006.050491

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

Review 1.  Hepatitis C and renal disease: an update.

Authors:  Catherine M Meyers; Leonard B Seeff; Catherine O Stehman-Breen; Jay H Hoofnagle
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Cloning of TLR3 isoform.

Authors:  Eunjeong Yang; Jeon-Soo Shin; Hyemi Kim; Hyoung Woo Park; Myoung Hee Kim; Se Jong Kim; In-Hong Choi
Journal:  Yonsei Med J       Date:  2004-04-30       Impact factor: 2.759

3.  Toll signaling: RIPping off the TNF pathway.

Authors:  Gregory M Barton; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2004-05       Impact factor: 25.606

4.  A toll-like receptor that prevents infection by uropathogenic bacteria.

Authors:  Dekai Zhang; Guolong Zhang; Matthew S Hayden; Matthew B Greenblatt; Crystal Bussey; Richard A Flavell; Sankar Ghosh
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

Review 5.  Innate immunity: the virtues of a nonclonal system of recognition.

Authors:  R Medzhitov; C A Janeway
Journal:  Cell       Date:  1997-10-31       Impact factor: 41.582

6.  Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.

Authors:  Hans-Joachim Anders; Volker Vielhauer; Vaclav Eis; Yvonne Linde; Matthias Kretzler; Guillermo Perez de Lema; Frank Strutz; Stefan Bauer; Mark Rutz; Hermann Wagner; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  FASEB J       Date:  2004-01-20       Impact factor: 5.191

7.  Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice.

Authors:  Jennifer R Timoshanko; A Richard Kitching; Yichiro Iwakura; Stephen R Holdsworth; Peter G Tipping
Journal:  J Am Soc Nephrol       Date:  2004-04       Impact factor: 10.121

Review 8.  Signaling danger: toll-like receptors and their potential roles in kidney disease.

Authors:  Hans-Joachim Anders; Bernhard Banas; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2004-04       Impact factor: 10.121

Review 9.  Toll-like receptor 3: a link between toll-like receptor, interferon and viruses.

Authors:  Misako Matsumoto; Kenji Funami; Hiroyuki Oshiumi; Tsukasa Seya
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

Review 10.  Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review.

Authors:  Y Uchiyama-Tanaka; Y Mori; N Kishimoto; A Nose; Y Kijima; T Nagata; Y Umeda; H Masaki; H Matsubara; T Iwasaka
Journal:  Clin Nephrol       Date:  2004-02       Impact factor: 0.975

View more
  47 in total

Review 1.  The role of Toll-like receptors in renal diseases.

Authors:  Anna Gluba; Maciej Banach; Simon Hannam; Dimitri P Mikhailidis; Agata Sakowicz; Jacek Rysz
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 2.  How the Innate Immune System Senses Trouble and Causes Trouble.

Authors:  Takashi Hato; Pierre C Dagher
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-20       Impact factor: 8.237

3.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

4.  PolyIC Induces Retinoic Acid-inducible Gene-I and Melanoma Differentiation-associated Gene 5 and Modulates Inflammation in Podocytes.

Authors:  Masamichi Nakata; Michiko Shimada; Ikuyo Narita-Kinjo; Daiki Nagawa; Kazutaka Kitayama; Misato Hamadate; Naotake Miura; Masashi Nozaka; Yosuke Kawamura; Takeshi Fujita; Reiichi Murakami; Tadaatsu Imaizumi; Norio Nakamura; Hirofumi Tomita
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

5.  Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier.

Authors:  Rahul D Pawar; Liliana Castrezana-Lopez; Ramanjaneyulu Allam; Onkar P Kulkarni; Stephan Segerer; Ewa Radomska; Tobias N Meyer; Catherine-Meyer Schwesinger; Nese Akis; Hermann-Josef Gröne; Hans-Joachim Anders
Journal:  Immunology       Date:  2008-10-24       Impact factor: 7.397

Review 6.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

Review 7.  Vasculitis: determinants of disease patterns.

Authors:  Gary S Hoffman; Leonard H Calabrese
Journal:  Nat Rev Rheumatol       Date:  2014-06-17       Impact factor: 20.543

Review 8.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 9.  Hepatitis C and its impact on renal transplantation.

Authors:  Jose M Morales; Fabrizio Fabrizi
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

Review 10.  Toll-like receptors in kidney disease.

Authors:  Kelly D Smith
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-05       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.